We had a fantastic time at this year’s SOT live meeting, reuniting with all our colleagues in the area of in vitro toxicology. Together with guest speakers from Takasago and Sonova, we presented new GARD data on agrochemical formulations, fragrance materials, medical devices and metals. We also introduced how in vitro methods can be used as a part of the biological evaluation of medical devices.  

Exhibitor Hosted Session: New GARD^® data on agrochemical formulations, fragrance materials, medical devices and metals

Together with guest speakers from Takasago and Sonova, our Scientific Liaison Dr Andy Forreryd presented the latest user cases where the in vitro GARD assays have been used for skin sensitization testing with a focus on the quantitative potency assessment.

Posters by SenzaGen and jointly with Sonova, Risk Science Consortium

🎫 P460 | Applicability domain of GARDskin | Request a copy
The GARDskin assay: Investigation of the applicability domain of indirectly acting haptens

🎫 P850 | Joint poster with Sonova | Request a copy
In vitro method for quantitative potency assessment of skin sensitizers during development of novel materials for intended use in medical devices

🎫 P846 | Joint poster with Risk Science Consortium | Request a copy
Ability of the GARD assay to replace the GPMT and the LLNA for assessment of the skin sensitization potential of medical devices

Highlights at our booth

Many visited our booth and discussed with our team to learn more about GARD and our expanded in vitro toxicity testing services. Our Medical Device and ISO expert Dr Rose-Marie Jenvert also introduced how we can guide our customers through the comprehensive process of biological evaluation of medical devices.